Dr Reddys advances on approvals for INDs
The company has received approvals for its three investigational new drugs (INDs). These INDs are used in the treatment of chronic obstructive pulmonary disease (COPD), dyslipidemia and artherosclerosis and associated cardiovascular diseases. The pharma major has also announced that it will merge its Drug Discovery operations with its wholly owned subsidiary Aurigene, effective from July … Read more Dr Reddys advances on approvals for INDs